Artificial Intelligence (AI) Optical Coherence Tomography (OCT) Market Report 2025

The artificial intelligence (AI) optical coherence tomography (OCT) market size has grown rapidly in recent years. It will grow from $1.84 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth during the historic period is driven by rising prevalence of eye diseases, increasing adoption in ophthalmology practices, higher healthcare spending in developed countries, growing demand for non-invasive diagnostic tools, expansion of hospital infrastructure, and broader reimbursement coverage in ophthalmology.

The artificial intelligence (AI) optical coherence tomography (OCT) market size is expected to see rapid growth in the next few years. It will grow to $3.25 billion in 2029 at a compound annual growth rate (CAGR) of 12%. The projected growth in the forecast period is supported by an aging population in emerging economies, greater use in ambulatory surgery centers, increased government healthcare funding, expansion of healthcare facilities in rural areas, rising demand for point-of-care diagnostics, and stronger policy support for diagnostic imaging. Key trends in this period include advancements in AI imaging, innovations in portable and handheld devices, development of multimodal imaging integration, creation of cloud-enabled workflow platforms, investment in teleophthalmology solutions, and adoption of synthetic three-dimensional imaging.

The rising incidence of ophthalmological diseases is anticipated to drive the growth of the artificial intelligence (AI) optical coherence tomography (OCT) market. Ophthalmological diseases refer to conditions that affect the eyes and visual system, potentially impairing vision or harming eye health. These diseases are becoming more common due to the increasing rates of diabetes, which damages retinal blood vessels and causes vision-threatening conditions. AI-based optical coherence tomography (OCT) plays a vital role in diagnosing eye diseases by providing high-resolution retinal imaging, which is ideal for early detection and continuous monitoring. By automating retinal scan analysis, it reduces diagnostic time, thus enhancing clinical efficiency and patient care. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that more than 3 million people in the United States were affected by glaucoma, and this number is projected to rise to 6.3 million by 2050. As a result, the increasing prevalence of ophthalmological diseases is fueling the growth of the AI optical coherence tomography market.

Key companies in the AI optical coherence tomography (OCT) market are concentrating on developing innovative products such as at-home OCT devices to improve diagnostic accuracy, support remote monitoring, and optimize ophthalmic workflows. These portable at-home devices enable patients to capture retinal scans at home for remote monitoring of eye conditions. For example, in May 2024, Notal Vision Inc., a healthcare company in the US, received de novo authorization from the US Food and Drug Administration (FDA) for its AI-powered SCANLY Home OCT device. This device is the first self-operated retinal imaging tool designed for monitoring wet age-related macular degeneration (AMD) in elderly patients. It uses spectral-domain optical coherence tomography (OCT) along with the AI-powered Notal OCT analyzer (NOA) to detect and assess retinal biomarkers, allowing for remote, high-resolution monitoring between clinical visits. The device securely transmits images to the Notal Health cloud for physician review and is supported by current procedural terminology (CPT) billing codes.

In May 2025, Topcon Healthcare Inc., a US-based eye care technology company, acquired RetInSight GmbH, a digital health firm based in Austria, for an undisclosed amount. This acquisition strengthens Topcon Healthcare’s AI optical coherence tomography (OCT) capabilities and enhances its digital eye care platform. The move is aimed at expanding the use of AI-driven retinal disease management and encouraging broader adoption of these technologies. RetInSight GmbH specializes in providing AI solutions for optical coherence tomography.

Major players in the artificial intelligence (AI) optical coherence tomography (OCT) market are Abbott Laboratories, Canon Inc., Carl Zeiss AG, Excelitas Technologies Corp., Topcon Corporation, Thorlabs Inc., Santec Holdings Corporation, Notal Vision Inc., Optopol Technology Sp. z o.o., BigVision Tech Inc., Shenzhen Certainn Technology Co. Ltd., Conavi Medical Inc., Wasatch Photonics Inc., RSIP Vision Ltd., Visionix Ltd., Altris AI Ltd., NIDEK Co. Ltd., Perimeter Medical Imaging AI Inc., Michelson Diagnostics Ltd., and Artelus Private Limited.

North America was the largest region in the artificial intelligence (AI) optical coherence tomography (OCT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) optical coherence tomography (OCT) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial intelligence (AI) optical coherence tomography (OCT) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Artificial intelligence (AI) optical coherence tomography (OCT) combines AI algorithms with optical coherence tomography imaging to automatically analyze high-resolution cross-sectional images of biological tissues, particularly the retina. This technology improves diagnostic accuracy, speed, and efficiency by identifying patterns, classifying diseases, and predicting condition progression across ophthalmology and other healthcare areas. It reduces dependence on manual interpretation and supports early detection and personalized treatment planning.

The primary types of AI optical coherence tomography (OCT) systems are table-top and portable devices. Table-top OCT devices are positioned on a table or cart, providing a stable upright setup, often with a headrest and scan mount for capturing images of seated patients. These systems use technologies such as time-domain OCT, spectral-domain OCT, and swept-source OCT, and are applied in hospitals, clinics, and similar healthcare settings.

The artificial intelligence (AI) optical coherence tomography (OCT) market research report is one of a series of new reports that provides artificial intelligence (AI) optical coherence tomography (OCT) market statistics, including the artificial intelligence (AI) optical coherence tomography (OCT) industry global market size, regional shares, competitors with the artificial intelligence (AI) optical coherence tomography (OCT) market share, detailed artificial intelligence (AI) optical coherence tomography (OCT) market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) optical coherence tomography (OCT) industry. This artificial intelligence (AI) optical coherence tomography (OCT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI) optical coherence tomography (OCT) market consists of revenues earned by entities by providing services such as image analysis, diagnostic interpretation, cloud-based storage services, training and education, and workflow integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) optical coherence tomography (OCT) market also includes sales of optical coherence tomography scanners, portable optical coherence tomography (OCT) devices, intravascular optical coherence tomography (OCT) systems, retinal imaging systems, multimodal imaging systems, and photoacoustic integrated optical coherence tomography (OCT) systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.